|
Lansoprazole and Naproxen
|
|
Prevacid NapraPAC
|
Lansoprazole and Naproxen Clinical Trials
- Efficacy of Lansoprazole in Chronic Post Nasal Drip
ClinicalTrials.gov Identifier: NCT00335283 - Recruiting
Larynx Disease
- Lansoprazole Preventing Gastroduodenal Stress Ulcerations
ClinicalTrials.gov Identifier: NCT00220909 - Recruiting
Patients Undergoing Elective Coronary Artery Bypass Graft
- Study to Evaluate the Incidence of Gastric Ulcers Following Administration of Either PN 200 or Naproxen in Subjects Who Are at Risk for Developing NSAID-Associated Ulcers.
ClinicalTrials.gov Identifier: NCT00367211 - Active, not recruiting
Osteoarthritis; Rheumatoid Arthritis; Ankylosing Spondylitis
- Safety and Efficacy of Ilaprazole 5, 20 and 40 mg QD and Lansoprazole 30 mg QD on Healing of Erosive Esophagitis
ClinicalTrials.gov Identifier: NCT00471094 - Active, not recruiting
Esophagitis
- Pharmacokinetic Study of Lansoprazole in Cystic Fibrosis
ClinicalTrials.gov Identifier: NCT00458614 - Active, not recruiting
Cystic Fibrosis
- Efficacy of Combination Product (Sumatriptan Succinate/Naproxen Sodium) in Eletriptan Non-Responders.
ClinicalTrials.gov Identifier: NCT00382993 - Recruiting
Migraine
- Efficacy of Combination Product (Sumatriptan Succinate/Naproxen Sodium) in Eletriptan Non-Responders.
ClinicalTrials.gov Identifier: NCT00383162 - Recruiting
Migraine
- Safety and Efficacy of Lansoprazole 30mg Twice Daily in Treatment of Laryngitis Associated With Gastroesophageal Reflux.
ClinicalTrials.gov Identifier: NCT00369265 - Recruiting
Laryngopharyngeal Reflux
- An Open-Label, Randomized, Comparative 3-Way Cross-Over Study to Evaluate the Effect of Food on the 24-Hour Intragastric pH at Day 5 After Twice Daily Oral Administration of PN 200 (Omeprazole/Naproxen) in Healthy Volunteers
ClinicalTrials.gov Identifier: NCT00442208 - Active, not recruiting
Healthy
- PRECISION : Prospective Randomized Evaluation of Celecoxib Integrated Safety vs Ibuprofen Or Naproxen
ClinicalTrials.gov Identifier: NCT00346216 - Recruiting
Osteoarthritis; Arthritis, Rheumatoid
- A Randomized, Single-Blind, Placebo-Controlled Study of Gastroesophageal Reflux Disease Therapy.
ClinicalTrials.gov Identifier: NCT00237068 - Recruiting
Asthma
- Lansoprazole to Treat Children With Asthma
ClinicalTrials.gov Identifier: NCT00442013 - Recruiting
Asthma
- Derris Scandens Benth Extract VS Naproxen in Knee OA
ClinicalTrials.gov Identifier: NCT00503828 - Recruiting
Knee Osteoarthritis
- Study of Flavocoxid (Limbrel) vs Naproxen in Subjects With Mod-Severe Osteoarthritis of the Knee
ClinicalTrials.gov Identifier: NCT00435292 - Recruiting
Osteoarthritis
- A Phase II Trial of Calcitriol and Naproxen in Patients With Recurrent Prostate Cancer
ClinicalTrials.gov Identifier: NCT00383487 - Recruiting
Prostate Cancer
- A Multicenter Trial of Rofecoxib and Naproxen in Alzheimer's Disease (NSAID Study)
ClinicalTrials.gov Identifier: NCT00004845 - Completed
Alzheimer Disease
- Oral Vs Rectal Admin of Naproxen for Post-Vag Perineal Pain Control
ClinicalTrials.gov Identifier: NCT00222976 - Completed
post-vaginal delivery perineal pain
- Tailored Treatment of H. Pylori Infection Based on SNPs of CYP2C19 and 23S rRNA of H. Pylori
ClinicalTrials.gov Identifier: NCT00149084 - Recruiting
H. pylori infection; Gastritis; Gastric ulcer; Duodenal Ulcer
- Celecoxib Versus Naproxen for Prevention of Recurrent Ulcer Bleeding in Arthritis Patients
ClinicalTrials.gov Identifier: NCT00153660 - Recruiting
Arthritis; Cardiovascular Diseases; Cerebrovascular Disorders
- Evaluation of 24-Hour Intragastric pH Using Esomeprazole, Lansoprazole, and Pantoprazole in Hispanic Patients With GERD
ClinicalTrials.gov Identifier: NCT00410592 - Completed
Gastroesophageal Reflux Disease
- Study Evaluating the Gastrointestinal Safety of PLA-695 Compared to Placebo and Naproxen
ClinicalTrials.gov Identifier: NCT00366262 - Completed
Healthy
- Intravenous vs Oral Lansoprazole on Gastric Acid Secretion in Subjects With Erosive Esophagitis.
ClinicalTrials.gov Identifier: NCT00175045 - Completed
Esophagitis; Reflux
- Efficacy/Safety of Lansoprazole in Patients With Frequent Heartburn
ClinicalTrials.gov Identifier: NCT00389948 - Completed
Heartburn
- Efficacy/Safety of Lansoprazole in Patients With Frequent Heartburn
ClinicalTrials.gov Identifier: NCT00390390 - Completed
Heartburn
- A Study to Compare the Efficacy and Safety of Dexlansoprazole and Lansoprazole on Healing of Erosive Esophagitis
ClinicalTrials.gov Identifier: NCT00251693 - Completed
Esophagitis, Reflux; Esophagitis, Peptic
- A Study to Compare the Efficacy and Safety of Dexlansoprazole and Lansoprazole on Healing of Erosive Esophagitis
ClinicalTrials.gov Identifier: NCT00251719 - Completed
Esophagitis, Reflux; Esophagitis, Peptic
- An Open Label pH Comparison of Esomeprazole and Lansoprazole in Barrett's Esophagus Patients
ClinicalTrials.gov Identifier: NCT00352261 - Completed
Barrett's Esophagus
- Study of 24-Hour Intragastric pH Profiles of Esomeprazole 40 Mg and Lansoprazole 30 Mg in Healthy Volunteer Subjects
ClinicalTrials.gov Identifier: NCT00230516 - Completed
Healthy
- The Use of Lansoprazole to Treat Infants With Symptoms of Gastroesophageal Reflux
ClinicalTrials.gov Identifier: NCT00324974 - Completed
Gastroesophageal Reflux Disease
- An Effectiveness and Safety Study of IDEA-033 in Comparison to Oral Naproxen and Placebo for the Treatment of Osteoarthritis of the Knee
ClinicalTrials.gov Identifier: NCT00211549 - Completed
Osteoarthritis, Knee
- A Long-Term Safety Study of IDEA-033 in Comparison to Oral Naproxen for the Treatment of Osteoarthritis of the Knee
ClinicalTrials.gov Identifier: NCT00265304 - Completed
Osteoarthritis, Knee
- Safety and Efficacy of Lumiracoxib Versus Naproxen in Acute Musculoskeletal Pain
ClinicalTrials.gov Identifier: NCT00170898 - Completed
Musculoskeletal Pain
- A Study to Evaluate the Effect of Lansoprazole on Hospitalized Neonates With Gastroesophageal Reflux Disease.
ClinicalTrials.gov Identifier: NCT00174928 - Completed
Gastroesophageal Reflux Disease
- A Study to Evaluate the Effect of Lansoprazole on Infants With Gastroesophageal Reflux Disease.
ClinicalTrials.gov Identifier: NCT00220818 - Completed
Gastroesophageal Reflux Disease
- Alzheimer's Disease Anti-Inflammatory Prevention Trial (ADAPT)
ClinicalTrials.gov Identifier: NCT00007189 - Completed
Alzheimer Disease
- Celebrex Los Dose ASA Study Examining the Incidence of Gastroduodenal Ulcers in a Healthy Population.
ClinicalTrials.gov Identifier: NCT00137033 - Completed
Peptic Ulcers
- Effects of Naproxen on Physical Performance
ClinicalTrials.gov Identifier: NCT00410995 - Terminated
Healthy
- Dental Pain (Following Third Molar Tooth Extraction) Study
ClinicalTrials.gov Identifier: NCT00114049 - Completed
Pain; Postoperative Pain
- A Safety and Effectiveness Study of Acetaminophen (4000 mg/Day) and Naproxen (750 mg/Day) in the Treatment of Osteoarthritis of the Hip or Knee
ClinicalTrials.gov Identifier: NCT00240773 - Completed
Osteoarthritis, Knee; Osteoarthritis, Hip
- A Study Comparing 4 Dose Regimens of PLA-695, Naproxen, and Placebo In Subjects With Osteoarthritis Of The Knee
ClinicalTrials.gov Identifier: NCT00396955 - Terminated
Osteoarthritis
- A Study of Rofecoxib Versus Naproxen in the Treatment of Chinese Patient with Rheumatoid Arthritis
ClinicalTrials.gov Identifier: NCT00157872 - Terminated
Rheumatoid Arthritis
[ Disclaimer: The information on GoldBamboo for any particular treatment, medicine, drug, or herbal product might be missing or incomplete, and should never be used as a single source of knowledge. GoldBamboo generally has links to authoritative sites displayed toward the bottom of each topic page under the heading "Resources". ]
| 
Not Signed In - 
email this page
print this page
bookmark this page
feedback on this page
